PCM
CELU icon

Penserra Capital Management’s Celularity CELU Stock Holding History

Penserra Capital Management’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-166
Closed -$5K – 1013
2022
Q2 		$5K Sell
166
-303
-65% -$24.6K ﹤0.01% 1349
2022
Q1 		$40K Buy
469
+14
+3% +$839 ﹤0.01% 1066
2021
Q4 		$23K Sell
455
-802
-64% -$51.3K ﹤0.01% 1218
2021
Q3 		$88K Buy
1,257
+291
+30% +$23.5K ﹤0.01% 839
2021
Q2 		$98K Sell
966
-570
-37% -$57.7K ﹤0.01% 795
2021
Q1 		$154K Sell
1,536
-54
-3% -$5.54K ﹤0.01% 627
2020
Q4 		$174K Buy
1,590
+1,420
+835% +$151K ﹤0.01% 552
2020
Q3 		$17K Buy
+170
New +$17.6K ﹤0.01% 757

Other funds holding CELU

SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
CVSC
C.V. Starr & Co New York $192M AUM 35.69% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LDFO
Louis-Dreyfus Family Office Wilton, Connecticut $64.7M AUM 21.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BRF
B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Penserra Capital Management's CELU Position: Q3 2022 in Review

Penserra Capital Management sold out of Celularity (CELU) in Q3 2022, closing a stake of 166 shares — an estimated $5K sold.

Penserra Capital Management first reported a position in CELU in Q3 2020 and held it in 8 quarters. The position peaked at $174K in Q4 2020. 72 funds tracked by Wall St. Rank hold CELU as of Q3 2022.

  • Penserra Capital Management reported no remaining Celularity position as of Q3 2022 after selling out during the quarter.
  • Penserra Capital Management sold 166 Celularity shares in Q3 2022, an estimated $5K.
  • Penserra Capital Management first reported a position in Celularity in Q3 2020 and held it in 8 quarters.
  • Penserra Capital Management's Celularity position peaked at $174K in Q4 2020.
  • 72 funds tracked by Wall St. Rank held Celularity as of Q3 2022.

Based on Penserra Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.